ABSTRACT
INTRODUCTION
During cell differentiation, transcriptional enhancers are bound by lineage-determining transcription factors (LDTFs) and play a key role in regulating cell type-specific gene expression. Cell type-specific enhancers are marked by specific epigenomic features (1) . Histone 3 lysine 4 (H3K4) mono-methylation (H3K4me1) is the predominant mark of a primed enhancer state. Histone 3 lysine 27 acetylation (H3K27ac) by H3K27 acetyltransferases CBP/p300 further follows H3K4me1 to mark an active enhancer state (2) . There are six mammalian Set1-like H3K4 methyltransferases, each containing a catalytic SET domain that enables the deposition of methyl marks on H3K4: MLL1 (or KMT2A), MLL2 (or KMT2B), MLL3 (or KMT2C), MLL4 (or KMT2D), SET1A (or KMT2F) and SET1B (or KMT2G) (3) . Among them, MLL4 is a major mammalian H3K4 mono-methyltransferase with partial functional redundancy with MLL3. MLL3 and MLL4 (MLL3/4) are required for CBP/p300-mediated enhancer activation in cell differentiation and cell fate transition (4) (5) (6) . Deletion of Mll3/4 genes depletes H3K4me1 in cells and prevents the enrichment of CBP/p300-mediated H3K27ac, epigenome reader BRD4, Mediator coactivator complex, and RNA Polymerase II on enhancers. Consequently, Mll3/4 deletion prevents enhancer RNA production, cell type-specific gene induction, and cell differentiation (7) . However, the role of H3K4me1 in enhancer regulation and cell differentiation, as well as H3K4me1 function in vivo, is poorly understood.
Adipogenesis and adipose tissue are useful model systems for studying cell differentiation as well as tissue development and function. Adipogenesis is mainly controlled by a cascade of sequentially expressed transcription factors (TFs) (8) . Although many TFs have been implicated in adipogenesis, PPAR␥ and C/EBP␣ are primary drivers of the induction of thousands of adipocyte genes (9, 10) . Adipose tissues, including white adipose tissue (WAT) and brown adipose tissue (BAT), are dynamic endocrine organs that regulate thermogenesis, energy metabolism and homeostasis (11) . The study of adipogenesis and adipose tissue in vivo requires the isolation of tissues from the adipose lineage at particular developmental and functional stages. Myogenic factor 5 (Myf5) promoter-driven Cre (Myf5-Cre) allows factors to be expressed or deleted in mouse preadipocytes, enabling a focus on adipogenesis. Conversely, Adiponectin promoter-driven Cre (Adiponectin-Cre, hereafter referred to as Adipoq-Cre) is generally expressed in differentiated adipocytes but not precursor cells, permitting study of adipocyte function (12) . By crossing Mll4 conditional knockout (KO) mice with Myf5-Cre or Adipoq-Cre mice, we have shown that MLL4 is required for adipose tissue development but largely dispensable for adipose tissue maintenance (4, 5) . However, the roles of MLL3/4 enzymatic activities and MLL3/4-mediated H3K4me1 in adipose tissue development and function are unclear.
By tissue-specific ectopic expression of a histone H3.3 lysine-to-methionine mutant (H3.3K4M) in mice, we show that depletion of H3K4 methylation by H3.3K4M impairs adipose tissue and muscle development. By tissuespecific deletion of the enzymatic SET domain of MLL3/4 in mice, we further show that the SET domain is required for adipose tissue and muscle development. Mechanistically, expression of H3.3K4M or deletion of the SET domain prevents MLL3/4-mediated enhancer activation in adipogenesis by destabilizing MLL3/4 proteins. Interestingly, H3.3K4M does not affect adipose tissue maintenance nor the thermogenic function.
MATERIALS AND METHODS

Plasmids, antibodies and chemicals
The retroviral pQCXIP plasmids expressing FLAG-tagged wild type (WT) or mutants of histone H3.3 including K4M, K9M, K27M and K36 were described previously (13) . The following homemade antibodies have been described: anti-MLL4#3 (14) , anti-MLL3#3 (15) and anti-UTX (16) . Anti-RbBP5 (A300-109A), anti-BRD4 (A301-985A100) and anti-MED1 (A300-793A) were from Bethyl Laboratories. Anti-SET1A/B antibodies were described previously (17) . Anti-H3 (ab1791), anti-H3K4me1 (ab8895), anti-H3K4me2 (ab7766), anti-H3K27ac (ab4729) and H3K36me3 (ab9050) were from Abcam. Anti-MLL1N (A700-010), anti-MLL1C (A300-374A), anti-MLL2 (ABE500), anti-Pol II (17-672), anti-H3K4me3 (07-473), anti-H3K9me2 (17-648), anti-H3K27me3 (07-449) and anti-H3K36me2 (07-369) were from Millipore. Anti-FLAG-M2 (F3165) and (Z)-4-hydroxytamoxifen (4OHT) (H7904) were from Sigma. Drosophila spike-in chromatin (53083) and antibody (61686) were from Active Motif.
Generation of mouse strains
To generate LSL-K4M transgenic mice, H3.3K4M and a 3 FLAG tag (H3.3K4M-FLAG) were fused downstream of CAG promoter with a loxP-STOP-loxP cassette in the middle of the pBT346.6 plasmid (AST-3029, Applied StemCell) (Figure 2A ). H3.3K4M-FLAG of pQCXIP-H3.3K4M was subcloned into the pBT346.6; after confirmation by DNA sequencing, the plasmid was linearized by SpeI and ScaI, gel purified and injected into zygotes harvested from C57BL/6 mice. Founder mice were identified by genotyping. For genotyping the LSL-K4M alleles, PCR was done using the following primers: 5 -CTAGCTGCAGCTCG AGTGAACCATGGC-3 and 5 -TTCGCGGCCGCGA ATTCCTAGGCGTAGTCG-3 . PCR amplified 524 bp from the LSL-K4M alleles. Total genomic DNA was extracted from mouse tail samples and PCR was done using Quick-Load ® Taq 2X Master Mix (NEB), following the manufacturers' instructions.
Mll3 f/f mice were obtained from Lee (18) (Figure 5A , left panel). To generate Mll4SET conditional KO mice, the loxP/FRT-flanked neomycin cassette was inserted at the 3 end of exon 51 and the single loxP site was inserted at the 5 end of exon 50 ( Figure 5A, right 
Histology and immunohistochemistry
E18.5 embryos were isolated and fixed in 4% paraformaldehyde, dehydrated in ethanol and embedded in paraffin for sectioning. Paraffin sections were stained with routine H&E or subjected to immunohistochemistry using anti-Ucp1 (ab10983; Abcam) and anti-Myosin (MF20; Developmental Studies Hybridoma Bank) antibodies as described (4) .
Immortalization of primary brown preadipocytes and adipogenesis
Primary brown preadipocytes were isolated from interscapular BAT of newborn (P0) LSL-K4M;Cre-ER or Mll3 f/f ;Mll4SET f/f ;Cre-ER pups, and immortalized by SV40T. Isolation, immortalization and adipogenesis assays of brown preadipocytes were done as described ( Figure 1A ) (19, 20) .
Western blot, qRT-PCR
Western blot of histone modifications using acid extracts or of nuclear proteins using nuclear extracts were done as described (21) . Total RNA was extracted using TRIzol (Invitrogen) and reverse transcribed using ProtoScript II firststrand cDNA synthesis kit (NEB), following the manufacturers' instructions. qRT-PCR was done using the following Quantitative PCR data in all figures are presented as means ± SEM. Statistical comparison between groups was performed using Student's t-test in all figures. WT at D7 was compared to K4M and K36M ( * * P < 0.01; * P < 0.05) from three biological replicates (n = 3). SYBR green primers: H3.3K4M (forward, 5 -AACCTGT GTGCCATCCACG-3 , and reverse, 5 -CGACTTGTCA TCGTCGTCCTT-3 ), Mll3 (forward, 5 -GATTGACGCC ACACTCACAG-3 , and reverse, 5 -TTTCTGTATCCTC CGGTTGG-3 ), and Mll4SET (forward, 5 -GGGTGGA GAGCTGTCAGAATTATT-3 , and reverse, 5 -CATGA GCGGTAACTCCATCAGA-3 ). SYBR green primers for other genes were described previously (22, 23) , and PCR was done using Luna® Universal qPCR Master Mix according to the manufacturers' instructions (NEB).
RNA-seq and ChIP-seq
RNA-seq and ChIP-seq were performed as described in detail previously with the use of Illumina HiSeq 2500 (4,6,7,24). Global differences in H3K4me1 and H3K27ac levels between control and K4M-expressing cells are not captured in ChIP-seq analysis if one uses naïve normalization, which simply normalizes the read counts by library size with the assumption that control and K4M cells have similar global histone modification levels. Therefore, H3K4me1 and H3K27ac ChIP-seq was done in the presence of Drosophila spike-in chromatin and antibody following the manufacturers' instructions (Active Motif). For RNA-seq, we purified mRNAs using Dynabeads mRNA purification kit (Invitrogen) then synthesized double-stranded cDNAs using SuperScript Doublestranded cDNA Synthesis kit (Invitrogen), following the manufacturers' instructions. For ChIP-seq, we collected ChIP-DNA using Dynabeads Protein A (Invitrogen) then purified DNA using QIAquick PCR Purification Kit (QI-AGEN), following the manufacturers' instructions. Library construction for RNA-seq and ChIP-seq was completed using NEBNext Ultra II DNA Library Prep Kit (NEB), following the manufacturers' instructions.
Computational analysis
For differentially expressed genes from RNA-seq data, gene ontology (GO) analysis was carried out using DAVID (https://david.ncifcrf.gov). For ChIP-seq data analysis with spike-in normalization, sequences were aligned to either mouse genome (mm9) or Drosophila genome (dm6). Normalization factors were determined by counting Drosophila tags and applying to mouse tags to generate normalized heat maps and profiles. To identify H3K4me1 or H3K27ac enriched regions at day 4 (D4) of adipogenesis in LSL-K4M;CreER brown preadipocytes, we used 'SICER' method (25) with window size of 200 bp and with an estimated false discovery rate (FDR) threshold of 10 −10 . Previously published ChIP-seq data sets for MLL4, PPAR␥ , C/EBP␣, CBP, BRD4 and MED1 at day 2 (D2) of adipogenesis were used (GSE50466, GSE74189, and GSE99101) (4,6,7) and the window size was chosen to be 50 bp. To define MLL4
+ active enhancers during adipogenesis, we compared 13 871 MLL4 binding sites at D2 with 38 618 active enhancers (H3K4me1 + H3K27ac + at D4). 8777 MLL4 + (22.7%, 8777/38 618) sites were located on active enhancers. Heat maps were generated with 50 bp resolution and ranked according to the intensity of 8777 MLL4 + active enhancers at the center. Average profiles were plotted using the number of ChIP-seq reads from the center of 8777 MLL4 + active enhancers to 5 kb on both sides.
RESULTS
Histone H3.3K4M and H3.3K36M mutations impair adipogenesis
Previous studies have identified histone H3.3 lysine-27-to-methionine (K27M) mutation in pediatric gliomas and H3.3 lysine-36-to-methionine (K36M) mutation in chondroblastoma (26, 27) . Knowledge of these mutations allows for their use as a tool in studying site-specific histone methylations, even outside the realm of cancer biology. Ectopic expression of histone H3.3 lysine-to-methionine (K-to-M) mutant specifically depletes endogenous lysine (K) methylation on histone H3 in cells (13, 28) . To understand the role of site-specific histone methylation in adipogenesis, we used retroviruses to stably express wild type (WT) or K-to-M mutant (K4M, K9M, K27M, or K36M) of histone H3.3 in brown preadipocytes. The expression levels of FLAGtagged H3.3 were much lower than that of endogenous H3 ( Figure 1B) . Consistent with previous reports (13, 28) , ectopic expression of H3.3K4M selectively decreased global H3K4me1, H3K4me2, H3K4me3 and H3K27ac levels, while H3.3K9M and H3.3K27M selectively decreased global levels of H3K9me2 and H3K27me3, respectively. Ectopic expression of H3.3K36M selectively depleted global H3K36me2 and moderately increased H3K27me3 levels ( Figure 1B ). Cells were induced to undergo adipogenesis. As shown in Figure 1C and D, H3.3K4M-expressing (K4M) cells showed severe defects in adipogenesis and associated expression of adipogenesis markers Pparg, Cebpa and Fabp4. Consistent with our recent report (24) , H3.3K36M-expressing cells also showed defects in adipogenesis. These results indicate that histone H3.3K4M and H3.3K36M mutations impair adipogenesis.
H3.3K4M impairs adipose tissue and muscle development
Next, we investigated whether H3.3K4M affects adipose tissue development in vivo. We generated a conditional H3.3K4M transgenic mouse line, lox-STOP-lox-H3.3K4M (LSL-K4M) for tissue-specific expression of H3.3K4M. The insertion of four copies of SV40 stop signals (STOP) flanked by two loxP sites prevents the CAG promoterdriven expression of FLAG-tagged H3.3K4M in the absence of Cre (Figure 2A and B) . We crossed LSL-K4M mice with Myf5-Cre mice to induce H3.3K4M expression specifically in somitic precursor cells of brown adipose tissue (BAT) and skeletal muscle (4) . No LSL-K4M;Myf5-Cre mice were observed at the weaning age. Newborn (P0) LSL-K4M;Myf5-Cre pups were obtained but died immediately after birth from breathing malfunctions due to deficient muscle groups in the rib cage ( Figure 2C-D) . Immunohistochemical analysis of cervical regions of LSL-K4M;Myf5-Cre E18.5 embryos and P0 pups revealed moderate reduction in BAT and back muscle mass ( Figure 2E , F and Supplementary Figure S1 ), indicating that expressing H3.3K4M in progenitor cells impairs adipose tissue and muscle development in vivo.
H3.3K4M destabilizes MLL3/4 proteins in adipogenesis
To confirm that H3.3K4M impairs adipogenesis in a cell autonomous manner, we crossed LSL-K4M with Cre-ER mice to obtain primary LSL-K4M;Cre-ER brown preadipocytes. After immortalization, cells were treated with 4-hydroxytamoxifen (4OHT) to delete the STOP cassette and induce FLAG-tagged H3.3K4M expression. As expected, induction of H3.3K4M expression decreased global levels of endogenous H3K4me1/2/3. Interestingly, H3.3K4M expression also decreased H3K27ac levels (Figure 3A) . Consistent with our previous findings observed in embryonic stem (ES) cells (21), expressing H3.3K4M destabilized endogenous MLL3/4 as well as the MLL3/4-associated protein UTX in cells. However, H3.3K4M did not affect protein levels of other mammalian Set1-like H3K4 methyltransferases SET1A, SET1B, MLL1 and MLL2 (15) (Figure 3B ).
Ectopic expression of H3.3K4M had little effect on cell proliferation ( Figure 3C ), but prevented adipogenesis and the induction of adipocyte marker genes such as Pparg, Cebpa, and Fabp4 ( Figure 3D and E). We confirmed these H3.3K4M-driven adipogenesis defects using independent brown preadipocyte lines stably expressing WT H3.3 or H3.3K4M (Supplementary Figure S2A-C) . To investigate how H3.3K4M prevents adipogenesis, we further performed RNA-seq analysis of LSL-K4M;Cre-ER preadipocytes treated with or without 4OHT. Using a 2.5-fold cut-off for differential gene expression from RNA-seq analysis, we defined genes up-regulated (5.0%, 605/12,179) or down-regulated (5.8%, 709/12 179) by H3.3K4M at D7 of differentiation ( Figure 3F and G) . Gene ontology (GO) analysis showed that down-regulated genes were strongly associated functionally with fat cell differentiation and lipid metabolism ( Figure 3H ). Because MLL3/4 are essential for adipogenesis (4), these data suggest that H3.3K4M prevents adipogenesis at least in part by destabilizing MLL3/4 proteins.
H3.3K4M prevents MLL3/4-mediated enhancer activation in adipogenesis
Next, we investigated whether H3.3K4M affects MLL3/4-mediated enhancer activation in adipogenesis. We performed ChIP-seq analyses of enhancer mark H3K4me1 and active enhancer mark H3K27ac in LSL-K4M;Cre-ER cells treated with or without 4OHT at D4 of adipogenesis. Since ChIP-seq analysis did not consider the global differences between samples, Drosophila spike-in control was used to normalize H3K4me1 and H3K27ac ChIP-seq data. Cell type-specific enhancers can be computationally defined by the binding of lineage-determining transcription factors and the enrichment of epigenomic features including H3K4me1, H3K27ac, MLL4, CBP, BRD4 and MED1 (1, 2, 4, 6, 7, 29) . By comparing with the published MLL4 ChIP-seq data during adipogenesis (4,6), we identified 38,618 MLL4 + active enhancers during adipogenesis. 4OHT-induced H3.3K4M expression prevented H3K4me1 and H3K27ac accumulation on MLL4 + active enhancers during adipogenesis ( Figure 4A and B) . H3.3K4M also prevented H3K4me1 and H3K27ac accumulation on representative MLL4 + active enhancers (e1-e5) located on gene loci of master adipogenic regulators PPAR␥ and C/EBP␣ (7). These active enhancers were defined by the binding of PPAR␥ and C/EBP␣, and by the enrichment of H3K4me1, H3K27ac, MLL4, CBP, BRD4 and MED1 during adipogenesis (4,6,7) ( Figure 4C ). Further, ChIP-qPCR analyses revealed that, on representative MLL4 + active enhancers (e1-e5), H3.3K4M markedly reduced the occupancy of MLL4, BRD4, MED1 and Pol II in addition to MLL3/MLL4-mediated H3K4me1 and CBP/p300-mediated H3K27ac ( Figure 4D ). H3.3K4M also decreased eRNA production from MLL4 + active enhancers ( Figure 4E ). Together, these results suggest that H3.3K4M prevents MLL3/4-mediated enhancer activation in adipogenesis.
Deletion of the enzymatic SET domain of MLL3/4 prevents adipose tissue and muscle development
MLL3 and MLL4 are partially redundant as major H3K4 mono-methyltransferases on enhancers in cells (4) . In a separate attempt to investigate the functional role of MLL3/4 enzymatic activity in differentiation and development in vivo, we used two conditional KO mouse lines targeting the enzymatic SET domain of MLL3 and MLL4 (Mll3 f/f and Mll4SET f/f , Figure 5A -B). In the Mll3 f/f mice, exons 57 and 58, which encode critical amino acids of the SET domain, were flanked by two loxP sites (18) . In the Mll4SET f/f mice, exons 50 and 51, which encode the entire SET domain, were flanked by two loxP sites. Cre-mediated deletion of these exons would result in the production of enzyme-dead MLL3/4.
We first crossed Mll4SET f/f mice with Myf5-Cre mice. The resulting Mll4SET f/f ;Myf5-Cre mice survived until birth. E17.5-18.5 Mll4SET f/f ;Myf5-Cre embryos were unable to breathe and died immediately after isolation, displaying an abnormal hunched posture and impaired back muscles (Supplementary Figure S3A and B) . These embryos showed similar BAT mass but altered BAT morphology and impaired muscle mass compared to WT (Supplementary Figure S3C ), possibly due to a compensatory effect of MLL3 as MLL4 KO alone does not affect MLL3 protein level (Supplementary Figure S4A and B) . To eliminate the compensatory effect, we crossed Mll4SET f/f with Mll3 f/f and Myf5-Cre mice to delete the SET domaincoding portion of both Mll3 and Mll4 genes in progenitor cells of BAT and muscle lineages. The resulting E18.5 Mll3 f/f ;Mll4SET f/f ;Myf5-Cre (conditional double KO, DKO) embryos were unable to breathe and died immediately after isolation. These embryos showed profound reduction of BAT as well as muscle mass ( Figure 5C-E) . These data indicate that deletion of the enzymatic SET domain of MLL3/4 prevents adipose tissue and muscle development.
Deletion of the enzymatic SET domain inhibits adipogenesis by destabilizing MLL3/4
To confirm that deletion of the enzymatic SET domain of MLL3/4 prevents adipogenesis in a cell autonomous manner, we crossed Mll3 f/f ;Mll4SET f/f mice with Cre-ER mice to obtain primary Mll3 f/f ;Mll4SET f/f ;Cre-ER brown preadipocytes. After immortalization, cells were treated with 4OHT to delete exons encoding the SET domain of MLL3/4. Consistent with our previous finding that MLL3 and MLL4 are major H3K4 mono-and dimethyltransferases in cells (4, 5) , deletion of the enzymatic SET domain in preadipocytes decreased global levels of endogenous H3K4me1/2 but not H3K4me3 ( Figure 6A ). In addition, deleting the enzymatic SET domain destabilized endogenous MLL3/4 and reduced protein levels of MLL3/4-associated UTX in cells (Figure 6B ), which is consistent with a recent report that deleting the SET domain destabilizes MLL3/4 in ES cells (30) .
Deletion of the enzymatic SET domain of MLL3/4 had little effect on cell proliferation ( Figure 6C ), but prevented adipogenesis and the induction of Pparg, Cebpa, and Fabp4 ( Figure 6D and E) . RNA-seq analysis at D7 of differentiation confirmed the deletion of target exons of both Mll3 and Mll4 loci ( Figure 6F) . We further performed RNAseq analysis of Mll3 f/f ;Mll4SET f/f ;Cre-ER preadipocytes treated with or without 4OHT. Using a 2.5-fold cut-off for differential expression from RNA-seq analysis, we defined genes up-regulated (5.1%, 623/12 184) or down-regulated (7.3%, 890/12 184) by deletion of the enzymatic SET domain at D7 of differentiation ( Figure 6G and H) . GO analysis showed that down-regulated genes were strongly functionally associated with fat cell differentiation and lipid metabolism ( Figure 6I ). These data suggest that deletion of the enzymatic SET domain inhibits adipogenesis by destabilizing MLL3/4.
H3.3K4M expression mimics MLL3/4 SET domain deletion in preventing adipogenesis
Next, we generated scatter plots of gene expression changes using RNA-seq data from cells with deletion of MLL3/4 SET domain (DKO) and cells with expression of H3.3K4M (K4M) ( Figure 7A) . A combined scatter plot revealed that down-or up-regulated genes were highly correlated between DKO and K4M cells ( Figure 7B ). We found that the majority of down or up-regulated genes at D7 of differentiation were shared by DKO and K4M ( Figure 7C and D) . The shared down-regulated genes were highly associated functionally with fat cell differentiation and lipid metabolism, whereas shared up-regulated genes were highly associated with cell proliferation and development ( Figure 7E and F) . These data suggest that ectopic H3.3K4M mimics the effect of Mll3/4 SET domain deletion in preventing adipogenesis.
H3.3K4M does not affect adipose tissue maintenance and thermogenic function
We also investigated the role of H3K4 methylation in adipose tissue maintenance and function in mice. For this purpose, we crossed LSL-K4M mice with Adipoq-Cre mice to achieve adipocyte-selective expression of H3.3K4M in vivo. Histone western blot of BAT from LSL-K4M;AdipoqCre mice showed that ectopic expression of H3.3K4M depleted endogenous H3K4me1/2/3 and MLL3/4 levels in BAT ( Figure 8A and B) . LSL-K4M;Adipoq-Cre mice did not show any discernable differences in body weight, fat/lean mass, or adipose tissue mass relative to control (LSL-K4M) mice at 8-10 weeks of age ( Figure 8C-E) . In the BAT, induction of H3.3K4M expression was successful in LSL-K4M;Adipoq-Cre mice, but the expression levels of adipocyte identity genes Pparg, Cebpa, and Fabp4 were similar between LSL-K4M;Adipoq-Cre and control mice ( Figure 8F ). This phenotype is consistent with what we have reported for the Mll4SET f/f ;Adipoq-Cre mice, in which MLL4 is dispensable for the maintenance of differentiated adipocytes in vivo (5) .
We further asked about the functional consequence of ectopic H3.3K4M expression in adipocytes in vivo. For this purpose, we acutely exposed the mice to environmental cold (6
• C) up to 6 h. LSL-K4M;Adipoq-Cre mice maintained normal body temperatures, were cold tolerant and behaved similarly to control mice in the cold tolerance test ( Figure  8G ). After cold exposure, expression levels of thermogenesis genes Ucp1, Dio2, and Elovl3 were similarly induced in BAT of LSL-K4M;Adipoq-Cre and control mice (Figure 8H) . Together, our data indicate that while H3.3K4M impairs adipose tissue development, it does not affect the maintenance nor the thermogenic function of adipose tissues. SET domain deletion are unstable in ES cells (30) . However, Rickels et al. reported that MLL3/4 proteins with SET domain deletion are stable in ES cells (31) . In our study, deleting exons 57 and 58 results in a destabilized MLL3 protein in cells ( Figure 6B ). In contrast, Rickels et al. deleted exons 56, 57 and 58 without affecting MLL3 protein stability in cells (31) . The full-length mouse MLL4 protein has 5588 aa. Dorighi et al. showed that a truncated MLL4 protein containing amino acids 1-5482 is unstable in ES cells (30) . In contrast, Rickels et al. showed that a more severely truncated MLL4 protein containing amino acids 1-5402 is stable in ES cells (31) . Future studies are needed to confirm that the SET domain is required for MLL3/4 protein stability in cells.
DISCUSSION
A previous report showed that H3K27M inhibits the H3K27 methyltransferase activity of Polycomb repressive complex 2 through interaction with the enzymatic subunit EZH2 (28) . Our data ( Figure 1B and Figure 3A ) and previous reports (13, 28) show that H3.3K4M reduces global levels of H3K4me1/2/3, suggesting that H3.3K4M inhibits the enzymatic activities of multiple SET1-like H3K4 methyltransferases including MLL3/4. The detailed biochemical mechanisms remain to be determined.
